Aspirin inhibits the formation of pentosidine, a cross-linking advanced glycation end product, in collagen

Diabetes Res Clin Pract. 2007 Aug;77(2):337-40. doi: 10.1016/j.diabres.2006.12.024. Epub 2007 Mar 26.

Abstract

Aspirin showed an inhibitory effect on the formation of pentosidine, a cross-linking advanced glycation endproduct, in collagen incubated with glucose in vitro. IC(50) was evaluated at 10mmol/l. Aspirin might act by metallic ion chelating (as did EDTA and DTPA) and by oxygen radical scavenging. Since aspirin was reported to inhibit retinopathy in diabetic dogs, it could act partly by inhibiting advanced glycation endproduct accumulation in long-lived proteins like collagens.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arginine / analogs & derivatives*
  • Arginine / antagonists & inhibitors
  • Aspirin / pharmacology*
  • Collagen / drug effects
  • Collagen / metabolism*
  • Cross-Linking Reagents
  • Glucose / pharmacology
  • Glycation End Products, Advanced / metabolism*
  • Glycosylation / drug effects
  • Lysine / analogs & derivatives*
  • Lysine / antagonists & inhibitors

Substances

  • Cross-Linking Reagents
  • Glycation End Products, Advanced
  • Collagen
  • Arginine
  • pentosidine
  • Glucose
  • Lysine
  • Aspirin